F³ Tech represents a concrete investment in domestic biomanufacturing infrastructure — advancing national competitiveness, supply chain resilience, and rural economic development through the development of agricultural and bioindustrial production capacity.
National Competitiveness
The United States faces a growing gap between its leadership in biological research and its capacity to manufacture biological products at commercial scale. Foreign competitors — particularly in Europe and Asia — have invested aggressively in biomanufacturing infrastructure, positioning their domestic industries to capture the production value of technologies that were often discovered in American laboratories.
Closing this gap requires distributed domestic investment in biomanufacturing infrastructure — not only at the commercial scale, but at the pilot and scale-up stage where most technologies currently stall. F³ Tech addresses this need directly, providing the pilot-scale manufacturing infrastructure that enables American biological innovations to advance toward commercial production within the United States.
Follow-On Investment Raised
Revenue Generated
Companies Supported
Jobs Created
“The ability to manufacture biological products at scale is increasingly a matter of national security and economic competitiveness.”
Supply Chain Resilience
The COVID-19 pandemic exposed the fragility of supply chains that depend on geographically concentrated or foreign-controlled production. Biological products — agricultural inputs, industrial enzymes, bio-based materials, and biosecurity-relevant compounds — are not immune to these vulnerabilities.
Building domestic pilot-scale and commercial biomanufacturing infrastructure is a supply chain resilience investment. It creates the U.S.-based production capacity that reduces dependence on foreign manufacturing for biological products that are strategically important to agriculture, industry, and national security. F³ Tech is a tangible contribution to that capacity — operating today, with demonstrated results.
Economic Development
The economic development impact of F³ Tech extends beyond the direct employment and revenue generated by the facility itself. It catalyzes the development of a regional bioindustrial cluster — attracting new companies, creating supply chain activity, developing workforce capabilities, and generating tax revenue and economic activity across the broader Eastern Shore economy.
Investment Opportunities
Continued investment in F³ Tech’s infrastructure — whether through public programs, strategic corporate partnerships, or direct capital investment — supports the expansion of the facility’s capabilities, the growth of the Bio Peninsula cluster, and the broader development of domestic biomanufacturing capacity. The return on this investment is measured not only in direct financial terms, but in the economic development, job creation, and supply chain resilience that the facility enables.
Strategic Importance
F³ Tech’s mission is directly aligned with federal priorities for domestic biomanufacturing, agricultural biotechnology, and bioeconomy development. Executive orders, agency strategic plans, and congressional legislation have all recognized the need to accelerate domestic biomanufacturing capacity — particularly in agricultural and non-pharmaceutical biological production.
F³ Tech is positioned to serve as a model and a resource for federal programs advancing these priorities — whether through direct program participation, technology demonstration, workforce development collaboration, or policy input on the regulatory and infrastructure conditions needed to build a competitive domestic bioeconomy.
